Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2007-06-30
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Multi-Channel Gastric Electrical Stimulation for the Treatment of Gastroparesis
NCT00595621
Study of Enhanced Programming Stimulation with the Enterra® Therapy System
NCT06560307
Thoracic Neuromodulation for Diabetic Gastroparesis
NCT05273788
Temporary Gastric Electrical Stimulation for Drug Refractory Gastroparesis
NCT00432835
Escalating Temporary Gastric Electrical Stimulation (GES) for Severe Gastroparesis
NCT02164591
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Treatement
All subjects that meet the requirement for gastric stimulator placement
Enterra Gastric Pacemaker
Gastric Pacemaker
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Enterra Gastric Pacemaker
Gastric Pacemaker
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Indiana University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0705-32
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.